SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:149212805"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:149212805" > Downregulation and ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features

Xing, XL (author)
Mu, NN (author)
Karolinska Institutet
Yuan, XT (author)
show more...
Wang, N (author)
Juhlin, CC (author)
Karolinska Institutet
Straat, K (author)
Larsson, C (author)
Karolinska Institutet
Neo, SY (author)
Xu, DW (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2022-03-08
2022
English.
In: Cancers. - : MDPI AG. - 2072-6694. ; 14:6
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Promoter mutations of the telomerase reverse transcriptase (TERT) gene occur frequently in thyroid carcinoma (TC), including papillary (PTC) and anaplastic subtypes (ATC). Given that the ETS family transcription factors GABPA and GABPB1 activate the mutant TERT promoter and induce TERT expression for telomerase activation, GABPB1 has been proposed as a cancer therapeutic target to inhibit telomerase. Here, we sought to determine the role of GABPB1 in TC pathogenesis. In TC-derived cells carrying the mutated TERT promoter, GABPB1 knockdown led to diminished TERT expression but significantly increased invasive potentials in vitro and metastatic potential in a xenograft zebrafish model and altered expression of markers for epithelial-to-mesenchymal transition. GABPB1 expression was downregulated in aggressive TCs. Low GABPB1 expression correlated with its promoter hypermethylation, which in turn was also associated with shorter disease-free survival. Consistently, DNA methylation inhibitors enhanced GABPB1 expression, as observed upon reduced promoter methylation. Our results suggest that GABPB1 is required for TERT expression and telomerase activation, but itself serves as a tumor suppressor to inhibit TC progression. Furthermore, aberrant DNA methylation leads to GABPB1 silencing, thereby promoting TC aggressiveness. Thus, caution is needed if targeting GABPB1 for cancer therapy is considered.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Cancers (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view